KEY WORDS: Bleeding gums, depression, duloxetine, serotonin norepinephrine reuptake inhibitors uloxetine is a recently introduced drug and is being fluoxetine up to 60 mg/ day and escitalopram up to 20 mg/ promoted as an effective antidepressant with significant day, as the patient had chosen pharmacotherapy at the action on the physical symptoms that commonly accompany beginning of the treatment. There was only minimal depression in the Indian population. It has got additional improvement in his symptoms with the medicines. indications for stress incontinence and fibromyalgia. [1] This case reports highlights an uncommon side-effect of the drug, thereby
Following the introduction of duloxetine in the local market, the advising the prescribers to be cautious about the same.
treating team decided to try it as it acts on both, the noradrenergic and serotonergic systems. He was put on 20 mg/day and the dose Case History was gradually increased to 40 mg/day in two divided doses after two weeks. The patient didn't report any significant side-effect "My life has become a story of sufferings and my body is the apart from a mild exacerbation of his epigastric pain that housing for all the possible diseases" is the way Mr. AD would responded well to a proton pump blocker that he took for four 029, India
D express his anguish and frustration of suffering from a major depressive episode with multiple somatic complaints whose cause could not be ascribed ascertained to any of the body systems in spite of two files full of investigation reports. He used to feel low throughout the day and had lost his interest in pleasurable activities like watching TV, chatting with others or even playing with his newly born daughter. He had difficulty in concentrating and his appetite had decreased. Although he never contemplated suicide, he found his life meaningless. The patient also had multiple somatic complaints in the form of a vague aching sensation in his head, chest and generalized myalgia.
He had been having these problems for over a year and had been on tri cyclic antidepressants (TCA), namely amitryptiline up to 200 mg/ day, nortryptiline up to 175 mg/ day and selective serotonergic reuptake inhibitors (SSRI) group, namely days. After 10 days of hiking the dose to 40 mg/day he developed bleeding from the gums. He noticed traces of blood in his saliva in the morning while spitting. His gums had become raw and blood oozed from their surface. The bleeding was minimal but was alarming to the patient and his family and they returned for review a week after the onset of bleeding. There was no change in his dietary habits or any new drug intake during this time. He did not consume alcohol and never had any significant medical illness. He never had any problem with his teeth or gums and had never been to a dentist before.
A dental referral did not reveal any local cause of the bleeding. Balhara, et al.: Bleeding gums � all within the normal range. Routine hemogram, renal and liver function tests were also within the normal range. Considering the temporal correlation of the bleeding to duloxetine, the drug was withdrawn. Over the next one week the bleeding from his gums resolved and the patient was continued on tricyclic antidepressants. The patient is currently in partial remission of depression and has not reported any further episodes of gum bleeding. A score of four was obtained on Naranjo's algorithm for adverse drug reaction which implicated duloxetine as a possible cause of the event.
Discussion SSRI have been shown to inhibit nitric oxide synthase, which leads to decreased production of nitric oxide from the nitric oxide donor, L-arginine. Nitric oxide is essential to activate guanylate cyclase for stimulating the formation of cyclic guanosine monophosphate (cGMP), which acts to relax smooth muscle and regulate platelet aggregation. This reduced cGMP may be responsible for SSRI-induced bleeding. The exact pathophysiology of duloxetine-induced bleeding is not known but may be associated with the same mechanism.
[5] The impairment of the platelet aggregation could be a possible mechanism of occurrence of the event. It may also be advisable to provide ulcer protective agents to old patients and patients who are taking anti-inflammatory agents when SSRI are Duloxetine is a dual reuptake inhibitor of synaptic serotonin prescribed to them. Physicians should be aware of this sideand norepinephrine. In contrast to other dual reuptake effect when prescribing duloxetine to their patients and more inhibitor antidepressants, duloxetine appears to exert clinically cautious postmarketing surveillance is needed to ascertain any demonstrable effects on both noradrenergic and serotonergic new side-effect. neurotransmission at starting doses.
[2] It is described as an SNRI (selective serotonin norepinephrine reuptake inhibitors). The However, the observed side-effects in this particular case might efficacy of duloxetine for depression has been established in be worth considering as in this case the parameters of platelet controlled trials using 40-120 mg/day. The most frequently count, bleeding time, clotting time, APTT and PTT were observed adverse events with duloxetine are nausea, dry mouth within the normal range. Moreover, the absence of the effect and somnolence. [3] Other side-effects attributed to the drug with fluoxetine and escitalopram in the past might point to a are constipation, diarrhea, decreased appetite, weight loss and novel mechanism of the side-effect. feeling of fatigue, dizziness, hypohidrosis, decreased libido and erectile dysfunction.
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